Want to join the conversation?
$TYPE's updated outlook also includes 3Q16 net income expectation in the range of $2-4.1MM, down from the earlier issued guidance of $5.5-7.2MM. For FY16, $TYPE expects net income in the range of $14.9-19MM, down from the earlier guidance of $25.4-28.6MM. Diluted EPS for 3Q16 & FY16 is expected in the range of $0.05-0.10 & $0.37-0.48 respectively.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.